| RBC FUNDS (LUX)-EMERGING MARKETS EQUITY FUND A CAP USD | RVI EMERGENTES | 26,24% | 35,42% | 30,46% | 110,38% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) CHF-H1 | BIOTECNOLOGÍA | 46,95% | 68,28% | 31,57% | 110,35% |
| GOLDMAN SACHS GLOBAL EQUITY INCOME PORTFOLIO E EUR CAP | RVI GLOBAL | 1,61% | 28,78% | 57,76% | 110,35% |
| INVESCO INDIA EQUITY A DIS ANNUAL USD | RVI ASIA EX-JAPÓN | -18,48% | 19,78% | 48,65% | 110,35% |
| JPM EMERGING MARKETS OPPORTUNITIES D (ACC) USD | RVI EMERGENTES | 28,61% | 31,01% | 7,01% | 110,33% |
| BGF EMERGING MARKETS EQUITY INCOME E2 EUR (HEDGED) | RVI EMERGENTES | 49,09% | 47,80% | 16,99% | 110,29% |
| JANUS HENDERSON GLOBAL LIFE SCIENCES B2 USD | BIOTECNOLOGÍA | 1,10% | 16,87% | 29,31% | 110,19% |
| BNP PARIBAS CHINA EQUITY PRIVILEGE CAP | RVI CHINA | 22,31% | 4,23% | -27,02% | 110,13% |
| AMUNDI FUNDS EQUITY MENA A USD (C) | RVI EMERGENTES | -2,06% | 21,23% | 63,40% | 110,06% |
| MFS MERIDIAN U.S. VALUE FUND IH1-EUR | RVI USA VALOR | 9,42% | 27,67% | 45,83% | 110,06% |
